TERT and glioma: Decision curve analysis indicated that the combined model provided greater clinical net benefit across threshold probabilities ranging from 0.15 to 0.85.<h4>Conclusion</h4>The integrated multiparametric radiomics model combining DKI and DCE-MRI enables noninvasive preoperative prediction of TERT promoter mutation status in gliomas with high accuracy.